Latest Ratios: P/E Ratio 106.1x · EV/EBITDA 43.9x · ROE 3.1%. (2018–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.4B | $3.1B | $2.5B | $2.9B | $2.5B | $2.8B | — | — | — |
| Enterprise Value | $1.9B | $2.6B | $2.0B | $2.5B | $2.2B | $2.5B | — | — | — |
| P/E Ratio → | 106.11 | 131.72 | 177.73 | 121.21 | — | — | — | — | — |
| P/S Ratio | 1.13 | 1.44 | 1.41 | 1.73 | 1.85 | 2.89 | — | — | — |
| P/B Ratio | 3.11 | 3.86 | 3.59 | 4.73 | 4.84 | 6.20 | — | — | — |
| P/FCF | 14.84 | 18.84 | 23.55 | 35.60 | 53.38 | 51.18 | — | — | — |
| P/OCF | 14.73 | 18.70 | 22.47 | 35.55 | 53.26 | 50.67 | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.22 | 1.13 | 1.50 | 1.60 | 2.60 | — | — | — |
| EV / EBITDA | 43.87 | 58.58 | 81.25 | 91.62 | — | — | — | — | — |
| EV / EBIT | 56.57 | 58.85 | 70.69 | 85.81 | — | — | — | — | — |
| EV / FCF | — | 15.94 | 18.90 | 30.87 | 46.24 | 46.15 | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 9.9% | 9.9% | 10.2% | 9.7% | 9.9% | 6.6% | 10.1% | 8.7% | 8.6% |
| Operating Margin | 1.6% | 1.6% | 1.0% | 1.2% | -1.4% | -22.5% | 3.1% | 2.0% | 0.3% |
| Net Profit Margin | 1.1% | 1.1% | 0.8% | 1.4% | -0.6% | -19.5% | 3.8% | 1.0% | -0.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | 3.1% | 3.1% | 2.2% | 4.1% | -1.8% | -63.4% | 24.9% | 8.5% | -3.5% |
| ROA | 1.8% | 1.8% | 1.3% | 2.6% | -1.2% | -37.1% | 10.4% | 3.2% | -1.2% |
| ROIC | 9.9% | 9.9% | 6.0% | 7.6% | -8.0% | -121.3% | 19.4% | 11.1% | 1.4% |
| ROCE | 4.6% | 4.6% | 2.6% | 3.6% | -3.7% | -64.1% | 15.1% | 10.6% | 1.5% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.10 | 0.23 | 0.40 | 0.78 |
| Debt / EBITDA | 0.22 | 0.22 | 0.23 | 0.30 | — | — | 1.24 | 2.46 | 20.78 |
| Net Debt / Equity | — | -0.59 | -0.71 | -0.63 | -0.65 | -0.61 | -0.35 | -0.04 | 0.32 |
| Net Debt / EBITDA | -10.65 | -10.65 | -20.02 | -14.02 | — | — | -1.87 | -0.22 | 8.65 |
| Debt / FCF | — | -2.90 | -4.66 | -4.73 | -7.15 | -5.03 | -1.32 | -0.20 | 5.55 |
| Interest Coverage | — | — | — | — | — | -203.21 | 13.24 | 2.32 | 0.34 |
Net cash position: cash ($480M) exceeds total debt ($10M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.60 | 1.60 | 1.86 | 1.81 | 2.09 | 2.35 | 1.29 | 1.12 | 1.14 |
| Quick Ratio | 1.60 | 1.60 | 1.86 | 1.81 | 2.09 | 2.35 | 1.29 | 1.12 | 1.14 |
| Cash Ratio | 0.84 | 0.84 | 1.09 | 1.01 | 1.32 | 1.68 | 0.58 | 0.41 | 0.39 |
| Asset Turnover | — | 1.55 | 1.53 | 1.66 | 1.71 | 1.41 | 2.48 | 2.91 | 2.64 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 68.93 | 66.46 | 64.02 | 51.01 | 44.35 | 44.28 | 35.90 | 39.50 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.9% | 0.8% | 0.6% | 0.8% | — | — | — | — | — |
| FCF Yield | 6.7% | 5.3% | 4.2% | 2.8% | 1.9% | 2.0% | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $129M | $126M | $125M | $111M | $108M | $106M | $106M | $103M |
Includes 30+ ratios · 8 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying PRVA stock.
Privia Health Group, Inc.'s current P/E ratio is 106.1x. The historical average is 143.6x.
Privia Health Group, Inc.'s current EV/EBITDA is 43.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 77.1x.
Privia Health Group, Inc.'s return on equity (ROE) is 3.1%. The historical average is -3.2%.
Based on historical data, Privia Health Group, Inc. is trading at a P/E of 106.1x. Compare with industry peers and growth rates for a complete picture.
Privia Health Group, Inc. has 9.9% gross margin and 1.6% operating margin.
Privia Health Group, Inc.'s Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Thin gross margins and EPS volatility
Metrics are mathematically derived from official filings.
Gross Margin Volatility Masks Underlying Stability
Gross margin swung from 9.4% in 2026Q1 to 1.9% in 2026Q2, per reported financials, reflecting lumpy value-based care settlements. Operating margin remains thin at 1.9%, suggesting limited operating leverage.
The dramatic quarterly swing in gross margin, from 9.4% to 1.9%, is characteristic of a business where shared savings are recognized on a lag and subject to true-ups. This volatility obscures the underlying trend: over the past year, gross margin has hovered in the 9-10% range, indicating a structurally thin but stable pass-through model. Operating margin, though improving to 1.9% in 2026Q2 from 1.2% in 2026Q1, remains compressed, implying that SG&A costs are scaling in line with revenue, limiting the earnings leverage that revenue growth might otherwise suggest.
ROIC Remains Subdued Despite Asset-Light Model
ROIC peaked at 3.2% in 2025Q3 but fell to 1.6% in 2026Q1, per financial statements, indicating that capital efficiency is not improving despite revenue growth. This suggests that investments in provider expansion are not yet yielding proportional returns.
ROIC has remained in the low single digits over the past ten quarters, with a peak of 3.2% in 2025Q3 and a recent reading of 1.6% in 2026Q1. This is despite an asset-light model with minimal fixed assets, implying that the capital base is largely composed of goodwill and intangibles from acquisitions, which do not generate direct returns. The modest ROIC suggests that the company is in a heavy investment phase, and investors should monitor whether the expansion in provider count eventually translates into higher returns on invested capital.
Working Capital Swings Distort Efficiency Metrics
DSO spiked to 41,332 days in 2026Q2, per reported figures, a data artifact from timing of receivables, while CCC is not calculable due to missing DIO. This highlights the lumpy nature of value-based care settlements.
The reported DSO of 41,332 days in 2026Q2 is clearly a data artifact, likely stemming from a timing mismatch in receivables recognition, and should be disregarded. More meaningful is the trend in DSO, which has ranged from 66 to 82 days over the past year, indicating a stable collection cycle. The cash conversion cycle is not calculable due to missing inventory data, but the extreme swings in operating cash flow, from -$177M to +$127M, suggest that working capital is a major source of volatility, driven by the timing of shared savings settlements.
Minimal Leverage Provides Strategic Flexibility
Debt-to-equity stands at 0.01 with interest coverage not reported, per financial statements, indicating a fortress balance sheet. This low leverage provides ample capacity to fund organic growth or weather margin pressure.
With total debt of only $8.7M against equity of $782.3M, Privia's leverage is negligible, and the D/EBITDA ratio of 577 in 2026Q2 is a distortion from near-zero EBITDA. This conservative capital structure is a strategic asset, allowing the company to invest in provider expansion without the burden of debt service. The absence of interest coverage data is not a concern given the minimal debt, but investors should note that the company's low leverage is a key differentiator versus peers like Centene, which carries a D/E of 0.94.
Strong Liquidity Position with Stable Current Ratio
Current ratio remains healthy at 1.62 in 2026Q2, with cash of $419.5M, per reported figures, providing ample buffer against short-term obligations. This liquidity is critical given the volatility in operating cash flow.
The current ratio has been stable around 1.6-1.9 over the past ten quarters, indicating a consistent ability to meet short-term liabilities. Cash reserves of $419.5M, combined with minimal debt, suggest that the company can withstand significant operational volatility, such as the negative FCF margin of -28% in 2026Q2. This liquidity position is a key support for the company's growth strategy, as it allows for continued investment in provider acquisition and technology without the need for external financing.
P/E Misleads in Low-Margin, High-Growth Model
The trailing P/E of 122.22 and forward P/E of 90.72, per market data, are misleading for a company with thin margins and lumpy earnings. EV/EBITDA of 52.15 better captures the operating economics.
The P/E ratio is commonly misapplied to Privia because its earnings are heavily influenced by non-cash items like stock-based compensation and timing of shared savings, making the denominator volatile and unrepresentative of underlying profitability. A more appropriate metric is EV/EBITDA, which at 52.15 reflects the market's valuation of the company's operating cash generation, though this too is elevated. Investors should also consider the forward EV/EBITDA of 4.05, which appears to be a data anomaly, and instead focus on the company's ability to convert revenue growth into sustainable EBITDA, given the thin gross margins.